Actuate Therapeutics Inc (ACTU) Directors and Executive Officers - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Actuate Therapeutics Inc   (NASDAQ: ACTU)

Actuate Therapeutics Inc

Officers & Directors




Actuate Therapeutics Inc currently has 12 employees.

  News about Actuate Therapeutics Inc Key Personnel

Actuate Therapeutics Set to Join Russell 2000 Amid Promising Advances in Pancreatic Cancer Treatment

In a significant milestone for Actuate Therapeutics, Inc. (NASDAQ: ACTU), a clinical-stage biopharmaceutical company dedicated to developing therapies for high-impact, difficult-to-treat cancers, the company is poised to be added to the Russell 2000 Index as part of the planned fourth quarter IPO additions. This inclusion is set to take effect after the U.S. market opens on December 23, 2024, signaling a growing recognition of Actuate s potential within the market.This news comes on the heels of Actuate s recent presentation at the American Association for Cancer Research (AACR) Special Conference on Advances in Pancreatic Cancer Research, where the company unveiled promising initial data from a Phase 2 clin...






ACTU Management Effectiveness ACTU Revenue per Employee ACTU Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.